This Hot Line Session titled ‘SGLT2 inhibition in heart failure,’ chaired by Marco Metra, Italy, and Mariell Jessup, US, saw the presentation of the full results of the DELIVER trial, supported by other analyses, to underpin the position of sodium-glucose cotransporter 2 (SGLT2) inhibitors as a cornerstone of treating heart...
ESC 2022 — DELIVER, supporting analyses uprear SGLT2 inhibitors in heart failure treatment
Drishti Agarwal | Conference Report | 01 September 2022
Register or log in to read more
Registration is free and easy, giving you complete access to all Univadis content.Create a Free Account I have an account